fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Sharon Bio-Medicine Ltd

Sharon Bio-Medicine Ltd

Updated on October 14, 2019

Stock/Share Code - SHARONBIO

Sharon Bio-Medicine Limited is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of pharmaceutical products. The Company operates in three segments, which include Active Pharma Ingredients (API's), Formulations and Toxicology.

Below is the details of SHARONBIO Sharon Bio-Medicine Ltd

Market Cap₹39.25 Cr.
Current Price ₹8.75 as on 13 Sep 17
52 Week High / Low Price₹7.43 / ₹2.95
Face Value₹2
Stock P/E3.23
Book Value-₹52.5
Dividend Yield0.00 %
ROCE-18.03 %
ROE-675 %
Sales Growth (3yrs)-31.40 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Formulations
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros:
Cons: Promoter's stake has decreased The company has delivered a poor growth of -12.58% over past five years. Promoter holding is low: 32.53% Company has a low return on equity of -25.34% for last 3 years.

Sharon Bio-Medicine Ltd Price Chart

Sharon Bio-Medicine Ltd Price Chart

Sharon Bio-Medicine Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Ajanta Pharma ₹1,012.35 22.55 ₹8,923.98 Cr. 0.88 ₹114.63 Cr. 8.36 19.76 611.94 23.85
2. ERIS Lifescience ₹422.6 17.20 ₹5,223 Cr. 0.00 ₹84.05 Cr. 17.96 9.39 274.30 35.35
3. Caplin Point Lab ₹396.85 17.07 ₹3,232.59 Cr. 0.51 ₹50.23 Cr. 34.20 31.47 192.55 48.53
4. Hester Bios ₹1,730.9 33.37 ₹1,388.41 Cr. 0.67 ₹8.39 Cr. -2.78 12.43 44.76 26.65
5. Bliss GVS Pharma ₹128.2 9.14 ₹1,101.11 Cr. 0.94 ₹33.79 Cr. -11.82 3.02 211.53 26.90
6. Amrutanjan Healt ₹360.3 34.72 ₹880.13 Cr. 0.51 -₹0.7 Cr. 54.55 24.69 44.60 25.31
7. Medicamen Biotec ₹139.5 34.69 ₹419.03 Cr. 0.28 ₹3.28 Cr. 1.86 -4.98 31.13 25.05
8. Sharon Bio-Med. 3.23 ₹39.25 Cr. 0.00 -₹56.19 Cr. 2.64 32.11 44.11 -18.03

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Sharon Bio-Medicine Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019
Sales463421223140353339324044
YOY Sales Growth %-59.62%-67.56%-41.99%-43.48%-31.59%19.14%68.82%53.52%25.57%-21.06%14.56%32.11%
Expenses353427242837362734283437
Material Cost %50.59%45.14%86.17%51.17%44.89%51.19%53.93%41.36%50.4%44.3%47.84%49.51%
Employee Cost %11.44%14.93%27.71%26.16%18.14%14.83%15.07%17.79%16.53%19.69%17.52%15.8%
Operating Profit110-6-234-165467
OPM %23%1%-31%-10%11%9%-2%19%12%12%15%16%
Other Income-19-06-9000-411-11-61
Interest559000000000
Depreciation551333233332
Profit before tax-19-10-11-9601-743-04-56
Tax %43%81%53%-0%0%0%-0%0%0%-0%0%-0%
Net Profit-11-2-5-9601-743-04-56
EPS in Rs-0.91-0.16-0.43-8.040.030.05-0.530.370.270.000.32-2.32
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016TTM
Sales891713354204966067851,0601,314834253155
Sales Growth %%91.91%95.67%25.45%18.27%22.06%29.54%34.96%24%-36.52%-80.71%%
Expenses751452963814455356909391,157868387134
Material Cost %80.05%81.13%85.06%86.89%84.41%83.29%83.56%85.14%84.7%96.95%131.09%%
Manufacturing Cost %1.77%1.53%1.13%0.89%1.46%1.45%1.25%1.02%0.95%2.77%7.05%%
Employee Cost %1.43%1.01%1.03%1.31%1.89%2.09%1.78%1.35%1.44%2.38%6.53%%
Other Cost %1.18%1.2%1.1%1.63%1.86%1.52%1.28%1.11%0.96%2.03%8.14%%
Operating Profit14263939527195120157-34-13421
OPM %16%15%12%9%10%12%12%11%12%-4%-53%14%
Other Income0122-01112-74-69-60
Interest12714212734435994710
Depreciation11446891215191511
Profit before tax132331222436536685-221-289-49
Tax %16%22%13%16%22%15%22%20%18%-2%-3%
Net Profit111827191931425370-226-299-49
EPS in Rs1.061.722.561.741.752.923.945.016.590.000.00-1.73
Dividend Payout %9%9%5%7%8%6%5%3%5%-0%-0%

Compounded Sales Growth

  • 5 Years:: -12.58%
  • 3 Years:: -31.40%
  • TTM:: 10.91%

Compounded Profit Growth

  • TTM:: -3784.25%

Return on Equity

  • 5 Years:: -4.97%
  • 3 Years:: -25.34%
  • Last Year:: -674.61%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016Mar 2019
Share Capital101011111111111121242424
Equity Capital10.0310.1810.5610.5610.5610.5610.5610.5621.1123.7923.79
Reserves1333708810413312817924281-219-648
Borrowings1665214262343344508644725824836827
Other Liabilities143634374398128139173838265
Trade Payables5.5121.5819.8722.6526.3132.3649.6759.8661.1751.2740.0346.2
Total Liabilities541453303975015867749721,1621,012723268
Fixed Assets9455256184181201272325332319180
Gross Block10.5948.4459.1367.06201.11206.42235.62317.87380.87406.69408.15
Accumulated Depreciation2.063.246.7810.9417.3425.5734.2946.3355.8574.5889.6
CWIP1015441072327604315002
Investments004144441100
Other Assets358422923329037450965482067840486
Inventories14.9326.2757.7589.66116.67155.21196.22260.24322.45301.42179.9928.48
Trade receivables16.3754.2794.94133.46158.77192.54260.12355.1414.31315.02183.1820.41
Cash Equivalents0.390.4372.623.352.393.846.286.2712.2716.0110.163.56
Loans n Advances3.292.913.556.4712.3822.5946.231.9863.3136.4121.771.26
Other Assets etc0.150.120.080.040.0100-0.018.119.529.1232.75
Total Assets541453303975015867749721,1621,012723268

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016
Cash from Operating Activity-5-14-40-50-28-36-53-70-69-82-28
Profit from operations14.0718.6235.0435.8446.3966.4185.73108.11143.95-112.6-213.84
Working Capital Changes-16.39-32.79-68.95-71.54-53.49-102.41-104.73-135.56-154.8124.34256.62
Taxes paid-2.660-6.58-14.36-210-33.98-42.78-58.62-93.64-70.98
Cash from Investing Activity-11-43-41-66-51-8-61-64-27-100
Fixed Assets Purchased-10.74-42.88-39.34-70.99-49.89-9.61-62.07-65.17-31.81-10.89-1.47
Investments purchased0-0.15-4.260-3.060-0.10000
Investments sold0003.120.220.25002.750.20.97
Cash from Financing Activity16571544778461171341039622
Proceeds from Shares04.511.240.360000066.830
Proceeds from Borrowings8.9749.01149.0151.0780.1545.6500117.2300
Repayment of Borrowings000-3.110-44.5900-35.7300
Dividends Paid-1-1.53-1.27-1.27-1.58-1.9-1.9-1.58-3.800
Net Cash Flow0072-69-112-064-6

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016
ROCE %34%19%11%11%13%15%15%16%-5%-18%
Debtor Days67116104116117116121122115138264
Inventory Turnover8.307.975.704.814.464.474.644.512.671.01

Announcements & News

Recent Announcements

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Sharon Bio-Medicine Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.